Open AccessNational Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection
Author(s) -
Ryan J. Ellis,
Jessie W Ho,
Cary Jo R. Schlick,
Ryan P. Merkow,
Karl Y. Bilimoria,
Anthony D. Yang
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-08023-1
Subject(s) - medicine , surgical oncology , chemotherapy , odds ratio , pancreatic cancer , stage (stratigraphy) , confidence interval , adenocarcinoma , cancer , surgery , oncology , paleontology , biology
Chemotherapy is increasingly administered prior to resection in patients with early-stage pancreatic adenocarcinoma, but the national prevalence of this practice is poorly understood. Our objectives were to (1) describe the utilization of upfront chemotherapy management of stage I pancreatic cancer; (2) define factors associated with the use of upfront chemotherapy and subsequent resection; and (3) assess hospital-level variability in upfront chemotherapy and subsequent resection.